Download free PDF

Infertility Treatment Devices Market Size & Share 2023 to 2032

Market Size by Type (Sperm Separation Devices, Ovum Aspiration Pumps, Sperm Analyzer Systems, Micromanipulator Systems, Incubators, Cryosystems, Imaging Systems, Microscopes).

Report ID: GMI6134
   |
Published Date: July 2023
 | 
Report Format: PDF

Download Free PDF

Infertility Treatment Devices Market Size

Infertility Treatment Devices Market size was valued at USD 319.3 million in 2022 and is estimated to account for USD 695.8 million by 2032.

Infertility Treatment Devices Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 319.3 Million
  • 2032 Forecast Market Size: USD 695.8 Million
  • CAGR (2023–2032): 8.4%

Key Market Drivers

  • Increasing prevalence of infertility worldwide.
  • High adoption of assisted reproductive technology (ART).
  • Technological advancements.
  • Increasing funding for infertility R&D.

Challenges

  • High cost of procedure.
  • Limited insurance coverage.

Infertility treatment devices are used to diagnose, treat, or aid in the treatment of infertility in individuals having trouble conceiving. These devices are used in a variety of procedures and therapies that target the root causes of infertility or support assisted reproductive technologies (ART). Further, the development of in vitro fertilization (IVF) and other assisted reproductive technologies (ART) have raised demand for infertility treatment devices, thereby predicted to stimulate market share.
 

Infertility is a multidimensional problem with economic, social, and cultural implications. Growing awareness regarding availability of infertility treatment devices globally in recent years will act as a driving factor for the industry expansion. Various government and private organizations aim at promoting awareness about infertility, surrogacy, and IVF procedures and improving infertility-related services globally. For instance, the National Infertility Awareness Week (NIAW) is a campaign intended to increase the awareness rate concerning infertility. In addition, growing understanding among the population base about the success rate of IVF procedures will further aid in market expansion.
 

COVID-19 Impact

The global pandemic affected millions of people worldwide, resulting into high mortality. The pandemic negatively impacted the infertility treatment devices market due to mobility constraints and safety concerns during several fertility procedures. Several organizations have undertaken initiatives to maintain reproductive health standards. Many infertility clinics were temporarily suspended, or their operations were limited during the peak of pandemic to prioritize urgent care and minimize the risk of COVID-19 transmission. This disruption resulted in the delay or cancellation of fertility treatment cycles, including the use of infertility treatment devices. Moreover, decline in the number of ART procedures at the beginning of COVID-19 affected the product demand in fertility clinics.
 

Infertility Treatment Devices Market

Infertility Treatment Devices Market Trends

Increase in the prevalence rate of infertility is attributed to various factors such as obesity and adoption of unhealthy dietary habits including excessive alcohol consumption & smoking, recreational drug consumption, among others. In addition, exposure to environmental pollutants and toxins can be extremely harmful to gametes (sperm and eggs), leading to infertility. Moreover, the rising infertility cases among women are owing to several disorders of the genital organs, growing age at conception, endocrine disorders which causes imbalances of reproductive hormones.
 

For instance, according to the American Pregnancy Association, nearly 30% of male population suffer from infertility and contributes to around one-fifth of infertility cases. Additionally, as per data from the Centers for the Disease Control and Prevention (CDC), around 12.1% of women, aged between 15 to 44 years are unable to conceive. Additionally, 6.7% of married women aged 15 to 44 years are infertile. Thus, the rising prevalence of infertility across the population base will stimulate market progress.
 

Infertility Treatment Devices Market Analysis

Infertility Treatment Devices Market Size, By Type,

The infertility treatment devices market by type is categorized into sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, cryosystems, imaging systems, microscopes, and others. The sperm separation devices segment garnered USD 55.4 million revenue size in the year 2022. Sperm separation devices are used in assisted reproductive treatments such as artificial insemination and in vitro fertilization (IVF). The upsurge can be attributed to its capacity to separate highly mobile sperm with competent DNA integrity from a sample of semen. Additionally, the sperm separation process removes sperms with defects such as bigger heads or twisted necks. Sperm separation arrays allow only the healthiest and most robust sperm to pass through.
 

Infertility Treatment Devices Market Share, By End-use

Based on end-use, the infertility treatment devices market is segmented into fertility clinics, hospitals & other healthcare facilities, and clinical research institutes. The fertility clinics segment accounted for over 80% business share in the year 2022 and is anticipated to witness highest growth during the forecast period. Fertility clinics have enhanced their infrastructure along with strengthening the portfolio including infertility services, thereby is anticipated to impel the segment growth. Adoption of several procedures is considerably high in fertility clinics due to substantial performance of surrogacy, IVF, procedures in facilities, thus escalating the demand for infertility treatments. Moreover, expanding number of specialized centers in emerging countries and rapid integration of advanced technologies at such facilities will propel industry demand.
 

U.S. Infertility Treatment Devices Market Size,

U.S. infertility treatment devices market accounted for USD 120.4 million revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline. Advancements in infertility treatment devices, favourable regulatory environment, and growing healthcare expenditure are the key driving factors for the U.S. market trends. Additionally, the presence of non-tax agencies that provide financial aid, the prevalence of charity trusts that provide funds for infertility treatments to infertile couples, and the significant presence of well-established market players, particularly in North America, will encourage market expansion in the upcoming years.
 

Infertility Treatment Devices Market Share

Some of the prominent market participants operating in the infertility treatment devices industry include:

  • CooperSurgical In
  • Vitrolife AB
  •  Cook Medical Inc 
  • Thermo Fisher Scientific Inc
  •  Merck KGaA
  •  Eppendorf AG
  •  Rocket Medical Plcs
  •  Art Biotech Pvt Ltd
  •  LabIVF Asia Pte Ltd
  •  Hamilton Thorne Inc
  • IVFtech ApS
  •  Dxnow (ZyMt Fertility, Inc.),

These market players are undertaking several growth strategies including partnerships, collaborations, acquisitions & mergers, and new product development & launches to strengthen their product portfolio as well as gain a competitive edge over others.
 

Infertility Treatment Devices Industry News:

  • In December 2022, Hamilton Thorne Ltd. acquired Microptic, S.L. The acquisition expands the company's expertise in the artificial intelligence-enabled product range and enhances its position in the computer-assisted semen analysis for IVF clinics market.
     
  • In July 2022, Cellink collaborated with Spermosens, Malmö University, and Saint Louis University (SLU). The goal of the partnership was to create a tool that could detect male infertility. Such initiative enabled in industry expansion.
     

Infertility treatment devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Type (USD Million & Units)

  • Sperm separation devices
  • Ovum aspiration pumps
  • Sperm analyzer systems
  • Micromanipulator systems
  • Incubators
  • Cryosystems
  • Imaging systems
  • Microscopes
  • Others

By End-use (USD Million)

  • Fertility clinics
  • Hospitals & other healthcare facilities
  • Clinical research institutes

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Switzerland
    • The Netherlands
    • Denmark
    • Poland
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • New Zealand
    • Thailand
    • Vietnam
    • Indonesia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Chile
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Turkey

 

Authors:  Mariam Faizullabhoy, Pratiksha Kamthe

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the infertility treatment devices market size?
Infertility treatment devices industry was worth USD 319.3 million in 2022 and is projected to record USD 695.8 million by 2032 attributed to the development of in vitro fertilization (IVF) and other assisted reproductive technologies.
Why is the demand for sperm separation devices gaining traction?
Sperm separation devices garnered USD 55.4 million in 2022 owing to the capacity of these devices to separate highly mobile sperm with competent DNA integrity from a sample of semen.
How big is the U.S. infertility treatment devices industry?
U.S. infertility treatment devices market amassed USD 120.4 million in 2022 and is estimated to witness steady growth through 2032 driven by the advancements in infertility treatment devices, favourable regulatory environment, and growing healthcare expenditure across the country.
Who are the leading players operating in the infertility treatment devices industry?
CooperSurgical, Inc, Vitrolife AB, Cook Medical Inc, Thermo Fisher Scientific Inc, Merck KGaA, Eppendorf AG, Rocket Medical Plcs, Art Biotech Pvt. Ltd, LabIVF Asia Pte Ltd, Hamilton Thorne, Inc, IVFtech ApS, and Dxnow (ZyM?t Fertility, Inc.) are some of the top firms engaged in the market.
Infertility Treatment Devices Market Scope
  • Infertility Treatment Devices Market Size

  • Infertility Treatment Devices Market Trends

  • Infertility Treatment Devices Market Analysis

  • Infertility Treatment Devices Market Share

Authors:  Mariam Faizullabhoy, Pratiksha Kamthe
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 12

Tables & Figures: 303

Countries Covered: 30

Pages: 215

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)